← Leaderboards
Ammon B Peck
University Of Florida
$4,831,038
Attributed
$4,831,038
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $766.5K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,831,038 · 9
By mechanism
R01$3,160,194 · 3
R21$1,015,684 · 3
R42$504,690 · 1
R43$149,676 · 1
M01$794 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Marguerite Hatch$8,759,200
- Raymond J Bergeron$10,920,022
- Nigel Gordon John Richards$2,138,341
- Jesse F. Gregory$5,806,114
- Saeed R Khan$4,180,448
Others in their field
Top investigators on “Sjogren'S Syndrome”
- Gary Andrew Weisman · University Of Missouri-Columbia$15,694,188
- Judith A James · Oklahoma Medical Research Foundation$13,537,735
- Sarah F Hamm-Alvarez · University Of Southern California$13,253,759
- Joel Marvin Guthridge · Oklahoma Medical Research Foundation$11,965,122
- Gary Fanger · Rise Therapeutics, Llc$10,611,116
- Antony Rosen · Johns Hopkins University$9,889,675
Research focus
Sjogren'S SyndromeNod MouseSalivary GlandsExocrine GlandsAcinar CellAutoantibodyPathologic ProcessPolymerase Chain ReactionB LymphocyteCytokineGenetically Modified AnimalsAutoimmunityFutureGene ExpressionFlow CytometryDiagnosis Design /EvaluationSouthern BlottingDisease /Disorder ModelHumoral ImmunityWestern BlottingsFunctional DisorderAnimal ModelExhibitsApoptosis
Grant awards (21)
Development of First Gen Oxalate Monitoring Test$149,676
R43 · FY2019 · DK · contact PI
Gene therapy targeting the Th17 / IL-27 system in autoimmune exocrinopathy$183,125
R21 · FY2010 · AI · contact PI
Gene therapy targeting the Th17 / IL-27 system in autoimmune exocrinopathy$219,750
R21 · FY2009 · AI · contact PI
Genetic Control of Autoimmune Exocrinopathy in NOD Mice$310,411
R01 · FY2007 · DE · contact PI
Genetic Control of Autoimmune Exocrinopathy in NOD Mice$319,682
R01 · FY2006 · DE · contact PI
Oxalobacter as a therapy in IBD-associated urolithiasis$213,121
R21 · FY2006 · DK · contact PI
Genetic Control of Autoimmune Exocrinopathy in NOD Mice$327,375
R01 · FY2005 · DE
Exocrine Gland Targeting in Autoimmune NOD Mice$256,496
R01 · FY2005 · DE
Oxalobacter as a therapy in IBD-associated urolithiasis$181,875
R21 · FY2005 · DK
IN VITRO DIFFERENTIATION OF CORD BLOOD STEM CELLS INTO ENDOCRINE PANCREAS FOR I$794
M01 · FY2005 · RR
Genetic Control of Autoimmune Exocrinopathy in NOD Mice$327,188
R01 · FY2004 · DE
Exocrine Gland Targeting in Autoimmune NOD Mice$256,823
R01 · FY2004 · DE
IL-4 Signaling Pathway Regulation of Sjogren's Syndrome$109,063
R21 · FY2004 · DE
Genetic Control of Autoimmune Exocrinopathy in NOD Mice$326,250
R01 · FY2003 · DE
Exocrine Gland Targeting in Autoimmune NOD Mice$257,122
R01 · FY2003 · DE
M3 Receptor--Diagnostic Marker for Sjogren's Syndrome$227,765
R42 · FY2003 · AI
IL-4 Signaling Pathway Regulation of Sjogren's Syndrome$108,750
R21 · FY2003 · DE
M3 Receptor--Diagnostic Marker for Sjogren's Syndrome$276,925
R42 · FY2002 · AI
Exocrine Gland Targeting in Autoimmune NOD Mice$257,392
R01 · FY2002 · DE
REGULATION OF ENTERIC HYPEROXALURI BY OXALOBACTER$264,560
R01 · FY2001 · DK
REGULATION OF ENTERIC HYPEROXALURI BY OXALOBACTER$256,895
R01 · FY2000 · DK